SUBSCRIBE
SUBSCRIBE

Brain cancer

Pictured: PET scan of the brain iStock/wehnt
Drug Development
Novocure Gets Phase III Win in Patients with Brain Metastases from Lung Cancer
Novocure’s stock spiked more than 15% Wednesday morning after the company announced its Tumor Treating Fields therapy met the primary endpoint in a late-stage trial.
March 27, 2024
 · 
3 min read
 · 
Tyler Patchen
Load More
PRESS RELEASES
Press Releases
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
April 3, 2025
 · 
4 min read
Press Releases
Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients
March 6, 2025
 · 
7 min read
Press Releases
Hoag Family Cancer Institute Leads National Effort to Combat Glioblastoma with Two New Clinical Trials
January 9, 2025
 · 
5 min read
Press Releases
CBTN Partners with Day One to Drive New Therapies for Pediatric Brain Tumors
December 17, 2024
 · 
2 min read
Press Releases
Lantern Pharma & Starlight Therapeutics Present LP-184 (STAR-001) Phase 1b Trial Design and Preclinical Data in Glioblastoma at Society for Neuro-Oncology (SNO) 2024 Highlighting Novel Synthetic Lethality
November 26, 2024
 · 
8 min read
Press Releases
TME Pharma Awarded €2.4 Million German Federal Grant to Support NOX-A12 Phase 2 Trial in Brain Cancer
October 31, 2024
 · 
6 min read
Press Releases
American Brain Tumor Association’s Metastatic Brain Tumor Collaborative Announces $50,000 Research Grant Opportunity to Fund High-Risk, High-Impact CNS Metastasis Research
October 31, 2024
 · 
3 min read
Press Releases
Aitia Expand Collaboration with Servier to Discover and Develop New Drugs for Brain Cancer Using AI-Driven Digital Twins
October 30, 2024
 · 
4 min read
Press Releases
FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
October 24, 2024
 · 
8 min read
Press Releases
FDA Awards Orphan Drug Designation for Brain Cancer Drug Development by Rosalind Franklin University Helix 51 Company
October 23, 2024
 · 
1 min read
Press Releases
Nikon Small World Competition Celebrates 50 Years with Groundbreaking Image of Brain Tumor Cells
October 18, 2024
 · 
19 min read
Press Releases
Biodexa’s MX-110 Continues to Show Promise in Recurrent Glioblastoma (rGBM), the Deadliest Brain Cancer
October 17, 2024
 · 
6 min read
Press Releases
Lausanne Researchers Combine 10x Genomics’ Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer
September 11, 2024
 · 
7 min read
Press Releases
EnClear Therapies, Inc. Secures Additional Funding to Advance Neuro-Oncology Innovations
September 4, 2024
 · 
2 min read
Press Releases
Telix Submits NDA for TLX101-CDx (Pixclara™) Brain Cancer Imaging Agent
August 28, 2024
 · 
8 min read
Press Releases
Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
August 15, 2024
 · 
4 min read
Press Releases
CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies
July 30, 2024
 · 
10 min read
Press Releases
Ipsen and Day One enter into exclusive ex-U.S. licensing agreement to commercialize tovorafenib for the most common childhood brain tumor
July 25, 2024
 · 
16 min read
Press Releases
NeOnc Initiates Cohort 3 in Phase 1 Clinical Trial of NEO212™, a Patented Novel Hybrid Drug Designed to Deliver ‘Double Punch’ Against Malignant Brain Tumors
July 25, 2024
 · 
6 min read
Pharm Country
IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology
February 14, 2024
 · 
8 min read